HomeOpen Access NewsResearch & Innovation

Research & Innovation

UK launches world’s first 3D forest mapping satellite to help fight climate change

A British-made satellite is expected to launch on April 29, which will help in the global fight against climate change.

Scientists find molecular reason for creation of chronic pain

A new study finds the exact molecular mechanism that turns acute pain into chronic pain - a condition that leads to the use of opioids and often, lifelong addiction.

Scientists find link between health policies and political favouritism

A new study reveals that WHO public health policies are poorly implemented in countries where corporations have influence via corruption and political favouritism.

Scientists witness white dwarf “switching on and off” for first time

For the first time, scientists have been able to witness a white dwarf "switching on and off" via a NASA satellite.

Scientists able to reverse negative effects of pain in brain

A study, published in Nature Neuroscience, finds that pain can block how dopamine functions - meaning that the negative effects of pain can theoretically be reversed.

European Innovation Council selects 65 start-ups to receive €363 million fund

The European Innovation Council has selected 65 start-ups and SMEs to receive €363 million of funding for breakthrough innovations.

Scientists say over half of virus survivors have Long COVID

According to scientists at Penn State College of Medicine, over half of virus survivors contract Long COVID.

Perseverance rover finds ancient lake and river systems on Mars

The NASA rover perseverance found evidence of ancient lake and river systems on Mars, a water system that was working 3.8 or 3.6 billion years ago.

Scientists identify gene linking severe COVID and Alzheimer’s

A new study has uncovered a gene that links severe COVID and Alzheimer's, via "immune system changes" that can happen in both conditions.

Piecing Glycoscience together

Frederique Lisacek from SIB Swiss Institute of Bioinformatics, discusses the experimental approaches towards Glycoscience and emphasises the need for collecting and integrating glyco-related information.

Merck “COVID pill” sold at forty-times what it costs to make

The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.

Monitoring changes occurring in the atmosphere

In the latest interview with Open Access Government, the National Center of Meteorology tell us more about their priority areas, such as the importance of earthquake monitoring.

The possibilities of sustainable space exploration

Open Access Government reflects on the meaning of sustainable space exploration, with a specific telescope in mind.

How can the NSF contribute to a global understanding of astronomy?

Open Access Government zeroes in on some of the most powerful telescopes in the world – specifically the promise of new discoveries in the Division of Astronomical Sciences (AST) Vera Rubin Observatory.

The COVID insight of Molecular and Cellular Biosciences

We reflect on the work of the Molecular and Cellular Biosciences division (MCB), especially in context of the “complex biological web” of a global pandemic.

Do the intellectual frontiers of physics impact other sciences?

When it comes to physics, the US National Science Foundation (NSF) are prolific in a range of projects – but do their discoveries shape collaborative scientific capacity?

Study finds Pfizer vaccine works at 90% efficacy for six months

The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders